| Year |
Citation |
Score |
| 2022 |
Jarosek SL, Virnig BA. Inference from Imprecisely Measured Exposures: Caution Is Needed When Using Health Insurance Data for Clinical Research: Commentary on an article by Karch M. Smith, BA, et al.: "The Effect of Sex Hormone Deficiency on the Incidence of Rotator Cuff Repair. Analysis of a Large Insurance Database". The Journal of Bone and Joint Surgery. American Volume. 104: e39. PMID 35506953 DOI: 10.2106/JBJS.22.00118 |
0.414 |
|
| 2020 |
Kalapara A, Watarai B, Jarosek S, Konety B. Pd40-03 Racial Disparities In Magnetic Resonance Imaging-Guided Biopsy For The Diagnosis Of Prostate Cancer In The United States The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000920.03 |
0.352 |
|
| 2019 |
Cross DA, Qin X, Huckfeldt P, Jarosek S, Parsons H, Golberstein E. Use of Medicare's Behavioral Health Integration Service Codes in the First Two Years: an Observational Study. Journal of General Internal Medicine. PMID 31845107 DOI: 10.1007/S11606-019-05579-2 |
0.486 |
|
| 2019 |
Sathianathen NJ, Fan Y, Jarosek SL, Konety I, Weight CJ, Vinogradov S, Konety BR. Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness. European Urology Focus. PMID 30797737 DOI: 10.1016/J.Euf.2019.02.007 |
0.387 |
|
| 2019 |
Sathianathen N, Fan Y, Jarosek S, Konety I, Weight C, Vinogradov S, Konety B. Mp05-18 Disparities In Bladder Cancer Treatment And Survival Amongst Elderly Patients With A Pre-Existing Mental Illness The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000554989.76933.99 |
0.328 |
|
| 2018 |
Franco RA, Fan Y, Jarosek S, Bae S, Galbraith J. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes. American Journal of Preventive Medicine. 55: S40-S48. PMID 30670200 DOI: 10.1016/J.Amepre.2018.05.030 |
0.303 |
|
| 2018 |
Sathianathen NJ, Jarosek SL, Fan Y, Krishna SR, Konety BR. Racial Disparities in Surgical Outcomes Among Males Following Major Urologic Cancer Surgery. American Journal of Preventive Medicine. 55: S14-S21. PMID 30670197 DOI: 10.1016/J.Amepre.2018.05.012 |
0.327 |
|
| 2018 |
Sathianathen NJ, Fan Y, Jarosek SL, Lawrentschuk NL, Konety BR. Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study. Urologic Oncology. PMID 29731413 DOI: 10.1016/J.Urolonc.2018.03.020 |
0.419 |
|
| 2018 |
Sathianathen N, Fan Y, Jarosek S, Lawrentschuk N, Konety B. Mp71-08 Finasteride Does Not Prevent Bladder Cancer: A Secondary Analysis Of The Medical Therapy For Prostatic Symptoms Study The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.2272 |
0.409 |
|
| 2017 |
Arsoniadis EG, Fan Y, Jarosek S, Gaertner WB, Melton GB, Madoff RD, Kwaan MR. Decreased Use of Sphincter-Preserving Procedures Among African Americans with Rectal Cancer. Annals of Surgical Oncology. 25: 720-728. PMID 29282601 DOI: 10.1245/S10434-017-6306-4 |
0.415 |
|
| 2017 |
Bolch CA, Chu H, Jarosek S, Cole SR, Elliott S, Virnig B. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments. Bmc Medical Research Methodology. 17: 93. PMID 28693428 DOI: 10.1186/S12874-017-0367-8 |
0.617 |
|
| 2017 |
Kwaan MR, Fan Y, Jarosek S, Elliott SP. Long-term Risk of Urinary Adverse Events in Curatively Treated Patients With Rectal Cancer: A Population-Based Analysis. Diseases of the Colon and Rectum. 60: 682-690. PMID 28594717 DOI: 10.1097/Dcr.0000000000000788 |
0.444 |
|
| 2017 |
Uloko M, Fan Y, Jarosek S, Konety B. MP53-04 COMPARISON OF THE LENGTH OF TIME FROM INITIATION OF ANDROGEN DEPRIVATION THERAPY TO SALVAGE CHEMOTHERAPY IN AFRICAN AMERICAN MALES AND CAUCASIAN MALES WITH CASTRATE RESISTANT PROSTATE CANCER Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1655 |
0.394 |
|
| 2016 |
Krishna S, Fan Y, Jarosek S, Adejoro O, Chamie K, Konety B. Racial disparities in active surveillance for prostate cancer. The Journal of Urology. PMID 27596691 DOI: 10.1016/J.Juro.2016.08.104 |
0.435 |
|
| 2016 |
Jarosek SL, Shippee TP, Virnig BA. Place of Death of Individuals with Terminal Cancer: New Insights from Medicare Hospice Place-of-Service Codes. Journal of the American Geriatrics Society. PMID 27534517 DOI: 10.1111/Jgs.14269 |
0.479 |
|
| 2016 |
Tward JD, Jarosek S, Chu H, Thorpe C, Shrieve DC, Elliott S. Time Course and Accumulated Risk of Severe Urinary Adverse Events After High-Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 27325475 DOI: 10.1016/J.Ijrobp.2016.03.047 |
0.34 |
|
| 2016 |
Zabell JR, Adejoro O, Jarosek SL, Elliott SP, Konety BR. Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis. World Journal of Urology. PMID 26914817 DOI: 10.1007/S00345-016-1790-X |
0.47 |
|
| 2016 |
Tward JD, Jarosek S, Chu H, Shrieve DC, Elliott S. Long-term comparative toxicity of LDR versus HDR prostate brachytherapy ± EBRT and evaluation of risk hazard over time: A SEER-Medicare analysis. Journal of Clinical Oncology. 34: 108-108. DOI: 10.1200/Jco.2016.34.2_Suppl.108 |
0.412 |
|
| 2016 |
Arsoniadis EG, Fan Y, Jarosek S, Chu H, Kwaan MR. Racial disparities in the surgical treatment of rectal cancer. Journal of Clinical Oncology. 34: e18080-e18080. DOI: 10.1200/Jco.2016.34.15_Suppl.E18080 |
0.376 |
|
| 2016 |
Jean-Baptiste C, Fan Y, Jarosek S, Konety B. PD08-08 RACIAL DISPARITIES IN THE FREQUENCY AND INTENSITY OF ACTIVE SURVEILLANCE FOR LOW RISK PROSTATE CANCER Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2824 |
0.406 |
|
| 2016 |
Arsoniadis EG, Fan Y, Jarosek SL, Gaertner WB, Melton GB, Madoff RD, Kwaan MR. Decreased Use of Sphincter-Preserving Procedures among African-American Patients with Rectal Cancer Journal of the American College of Surgeons. 223: S29. DOI: 10.1016/J.Jamcollsurg.2016.06.075 |
0.419 |
|
| 2015 |
Liberman D, Jarosek S, Virnig BA, Chu H, Elliott SP. The Patient Burden of Bladder Outlet Obstruction After Prostate Cancer Treatment. The Journal of Urology. PMID 26682759 DOI: 10.1016/J.Juro.2015.11.072 |
0.618 |
|
| 2015 |
Elliott SP, Fan Y, Jarosek S, Chu H, Downs L, Dusenbery K, Geller MA, Virnig BA. Propensity-Weighted Comparison of Long-Term Risk of Urinary Adverse Events in Elderly Women Treated For Cervical Cancer. International Journal of Radiation Oncology, Biology, Physics. 92: 586-93. PMID 25890845 DOI: 10.1016/J.Ijrobp.2015.02.025 |
0.574 |
|
| 2015 |
Jarosek SL, Virnig BA, Chu H, Elliott SP. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. European Urology. 67: 273-80. PMID 25217421 DOI: 10.1016/J.Eururo.2014.08.061 |
0.627 |
|
| 2015 |
Goldfarb R, Fan Y, Jarosek S, Chu H, Virnig B, Elliott S. MP9-11 LONG-TERM RISK OF UROLOGIC COMPLICATIONS FOLLOWING CERVICAL CANCER TREATMENT Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.371 |
0.564 |
|
| 2015 |
Liberman D, Jarosek S, Virnig B, Elliott S. PD47-07 SEVERE URINARY ADVERSE EVENTS AFTER HIGH VS. LOW DOSE RATE PROSTATE BRACHYTHERAPY: A POPULATION-BASED ANALYSIS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2751 |
0.543 |
|
| 2015 |
Liberman D, Jarosek S, Virnig B, Elliott S. MP27-18 BLADDER OUTLET OBSTRUCTION AFTER PROSTATE CANCER TREATMENT: A POPULATION-BASED ANALYSIS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1180 |
0.64 |
|
| 2013 |
O'Shaughnessy MJ, Jarosek SL, Virnig BA, Konety BR, Elliott SP. Factors associated with reduction in use of neoadjuvant androgen suppression therapy before radical prostatectomy. Urology. 81: 745-51. PMID 23465162 DOI: 10.1016/J.Urology.2012.12.044 |
0.581 |
|
| 2012 |
Elliott SP, Johnson DP, Jarosek SL, Konety BR, Adejoro OO, Virnig BA. Bias due to missing SEER data in D'Amico risk stratification of prostate cancer. The Journal of Urology. 187: 2026-31. PMID 22498210 DOI: 10.1016/J.Juro.2012.01.070 |
0.594 |
|
| 2012 |
Elliott SP, Adejoro OO, Konety BR, Jarosek SL, Dusenbery KE, Virnig BA. Intensity modulated radiation therapy replaces 3-dimensional conformal radiotherapy as prostate cancer treatment. The Journal of Urology. 187: 1253-8. PMID 22335868 DOI: 10.1016/J.Juro.2011.11.088 |
0.591 |
|
| 2012 |
Tuttle TM, Jarosek S, Habermann EB, Yee D, Yuan J, Virnig BA. Omission of radiation therapy after breast-conserving surgery in the United States: a population-based analysis of clinicopathologic factors. Cancer. 118: 2004-13. PMID 21952948 DOI: 10.1002/Cncr.26505 |
0.656 |
|
| 2012 |
Elliott S, Jarosek S, Virnig B. 422 PROTON BEAM RADIOTHERAPY IN THE US MEDICARE POPULATION GROWTH IN USE IN PROSTATE AND OTHER CANCERS BETWEEN 2006 AND 2009 Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.488 |
0.587 |
|
| 2011 |
Elliott SP, Jarosek SL, Alanee SR, Konety BR, Dusenbery KE, Virnig BA. Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture. Cancer. 117: 4557-65. PMID 21412999 DOI: 10.1002/Cncr.25994 |
0.549 |
|
| 2011 |
Groth SS, Virnig BA, Al-Refaie WB, Jarosek SL, Jensen EH, Tuttle TM. Appendiceal carcinoid tumors: Predictors of lymph node metastasis and the impact of right hemicolectomy on survival. Journal of Surgical Oncology. 103: 39-45. PMID 21031414 DOI: 10.1002/Jso.21764 |
0.532 |
|
| 2011 |
O'Shaughnessy MJ, Jarosek SL, Virnig BA, Konety BR, Elliott SP. 78 INTENSITY-MODULATED RADIOTHERAPY REPLACES 3-DIMENSIONAL EXTERNAL BEAM AS THE PREFERRED RADIOTHERAPY MODALITY IN PROSTATE CANCER Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.142 |
0.654 |
|
| 2011 |
Jarosek SL, Virnig BA, Feldman R. Palliative radiotherapy in medicare-certified freestanding hospices (Journal of Pain and Symptom Management (2009) 37, 5, (780-787) DOI: 10.1016/j.jpainsymman.2008.05.003) Journal of Pain and Symptom Management. 42: 329. DOI: 10.1016/J.Jpainsymman.2011.06.002 |
0.468 |
|
| 2010 |
Elliott SP, Jarosek SL, Wilt TJ, Virnig BA. Reduction in physician reimbursement and use of hormone therapy in prostate cancer. Journal of the National Cancer Institute. 102: 1826-34. PMID 21131577 DOI: 10.1093/Jnci/Djq417 |
0.635 |
|
| 2010 |
Elliott S, Jarosek S, Virnig B. 338 THE INFLUENCE OF PHYSICIAN FINANCIAL INCENTIVES ON INDICATED VS. NON-INDICATED ANDROGEN SUPPRESSION THERAPY Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.404 |
0.512 |
|
| 2010 |
Elliott S, Jarosek S, Virnig B. 55 SELECTION BIAS IN ASSIGNING D'AMICO RISK GROUPS WITH SEER DATA Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.101 |
0.483 |
|
| 2010 |
Alanee S, Jarosek S, Virnig B, Elliott S. 48 Three Dimentional External Beam Radiotherapy For Prostate Cancer Increases The Risk Of Hip Fracture The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.094 |
0.588 |
|
| 2010 |
Alanee S, Jarosek S, Virnig B, Elliott S. 47 HOW DOES LEVEL I EVIDENCE AFFECT TREATMENT TRENDS OF EBRT+AST COMBINATION THERAPY FOR PROSTATE CANCER? Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.093 |
0.613 |
|
| 2010 |
Alanee S, Jarosek S, Virnig B, Konety B, Elliott S. 7 HIGH RISK PROSTATE CANCER FEATURES ON DIAGNOSIS IN AFRICAN AMERICAN MALES: ANALYSIS OF THE MODERN SEER DATABASE Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.050 |
0.603 |
|
| 2009 |
Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Factors associated with contralateral prophylactic mastectomy use among breast cancer patients in a metropolitan hospital system. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6558. PMID 27963773 DOI: 10.1200/Jco.2009.27.15_Suppl.6558 |
0.643 |
|
| 2009 |
Jensen EH, Abraham A, Jarosek S, Habermann EB, Al-Refaie WB, Vickers SA, Virnig BA, Tuttle TM. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery. 146: 706-11; discussion 7. PMID 19789030 DOI: 10.1016/J.Surg.2009.06.056 |
0.631 |
|
| 2009 |
Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Annals of Surgical Oncology. 16: 2697-704. PMID 19653045 DOI: 10.1245/S10434-009-0641-Z |
0.652 |
|
| 2009 |
Christoforidis D, McNally MP, Jarosek SL, Madoff RD, Finne CO. Endocavitary contact radiation therapy for ultrasonographically staged T1 N0 and T2 N0 rectal cancer. The British Journal of Surgery. 96: 430-6. PMID 19283737 DOI: 10.1002/Bjs.6478 |
0.349 |
|
| 2009 |
Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1362-7. PMID 19224844 DOI: 10.1200/Jco.2008.20.1681 |
0.63 |
|
| 2009 |
Jarosek SL, Virnig BA, Feldman R. Palliative radiotherapy in Medicare-certified freestanding hospices. Journal of Pain and Symptom Management. 37: 780-7. PMID 18789642 DOI: 10.1016/J.Jpainsymman.2008.05.003 |
0.546 |
|
| 2009 |
Elliott SP, Wilt TJ, Jarosek S, Shen L, Virnig BA. DECREASED REIMBURSEMENT FOR ANDROGEN SUPPRESSION THERAPY DOES NOT LEAD TO WITHDRAWL OF CARE IN METASTATIC PROSTATE CANCER Journal of Urology. 181: 196-196. DOI: 10.1016/S0022-5347(09)60563-2 |
0.607 |
|
| 2009 |
Tuttle T, Jarosek S, Habermann E, Arrington A, Abraham A, Morris T, Virnig B. QS101. Rising Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma in Situ Journal of Surgical Research. 151: 286. DOI: 10.1016/J.Jss.2008.11.397 |
0.58 |
|
| 2007 |
Hartman L, Jarosek SL, Virnig BA, Durham S. Medicare-certified home health care: urban-rural differences in utilization. The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association. 23: 254-7. PMID 17565526 DOI: 10.1111/J.1748-0361.2007.00098.X |
0.478 |
|
| 2007 |
Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 109: 1736-41. PMID 17372919 DOI: 10.1002/Cncr.22599 |
0.618 |
|
| Show low-probability matches. |